| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 800 | ₹0.55 0% | 17,0500% |
| 2,3250% | ₹136.55 0% | 820 | ₹0.65 8.33% | 2,3250% |
| 4,6500% | ₹137.5 0% | 840 | ₹0.3 0% | 44,9500% |
| 7750% | ₹103.3 0% | 850 | ₹0.4 -42.85% | 18,6000% |
| 00% | ₹78.8 0% | 870 | ₹1 0% | 4,6500% |
| - | - | 880 | ₹0.6 -40% | 44,1750% |
| 7750% | ₹78.75 0% | 890 | ₹0.8 -46.66% | 29,450-2.56% |
| 13,1750% | ₹66.75 0% | 900 | ₹1.2 -46.66% | 1,54,225-2.45% |
| 3,1000% | ₹60.25 0% | 910 | ₹1.85 -40.32% | 41,0750% |
| 20,1500% | ₹41.6 0% | 920 | ₹3 -38.77% | 87,575-0.87% |
| 82,150-2.75% | ₹31.15 3.48% | 930 | ₹4.5 -35.71% | 67,42511.53% |
| 1,05,4009.67% | ₹23.55 1.94% | 940 | ₹7.1 -29.35% | 1,72,0502.30% |
| 1,77,47511.70% | ₹18.45 6.03% | 950 | ₹10.55 -26.98% | 1,00,750-2.25% |
| 2,39,4759.18% | ₹13.2 6.02% | 960 | ₹15.05 -23.6% | 1,71,275-5.15% |
| 1,80,575-3.31% | ₹8.9 0.56% | 970 | ₹24.35 -5.43% | 1,27,1000% |
| 3,96,800-3.03% | ₹5.9 -4.06% | 980 | ₹32.6 0% | 96,1000% |
| 2,89,850-1.31% | ₹3.85 -8.33% | 990 | ₹44.7 0% | 39,5250% |
| 7,02,15010.62% | ₹2.55 -12.06% | 1,000 | ₹44 -19.63% | 1,30,9750% |
| 82,9250.94% | ₹1.7 -15% | 1,010 | ₹61 0% | 7,7500% |
| 1,51,9000% | ₹1.05 -25% | 1,020 | - | - |
| 80,6000% | ₹0.95 -5% | 1,030 | - | - |
| 49,600-3.03% | ₹0.65 -13.33% | 1,040 | ₹66 0% | 1,5500% |
| 68,2002.32% | ₹0.55 -21.42% | 1,050 | - | - |
| 99,2000% | ₹0.35 -30% | 1,060 | - | - |
| 7750% | ₹1 0% | 1,070 | - | - |
| 12,4000% | ₹0.35 -30% | 1,080 | ₹125.8 0% | 3,1000% |
| 1,42,600-6.59% | ₹0.3 100% | 1,100 | ₹135.85 0% | 1,5500% |
| 13,175-5.55% | ₹0.2 -75% | 1,120 | - | - |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
